Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05713227
Other study ID # 414-1121
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 11, 2022
Est. completion date February 28, 2023

Study information

Verified date November 2023
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gellan gum (GG) is a food grade polysaccharide produced by fermentation. In-vitro studies and in vivo pilot studies suggest that adding gellan gum to rice during cooking might reduce the extent of the increase in circulating blood glucose seen after its consumption (glycaemic response). This study will explore whether such a modification in response is sustained, particularly over a period of 7 days of consumption.


Description:

BACKGROUND: Rice is a carbohydrate-rich staple source of food for around half of the world population. Consumption is estimated to be 480 million tonnes per year. According to The Food and Agriculture Organization of the United Nations (FAO), rice is easily accessible to people in Asia, Pacific region, parts of Latin America and the Caribbean and, increasingly in Africa. Rice plays an important role in achieving an adequate dietary intake in these countries. However high consumption of white rice has been linked with high obesity rates and increased risk for type 2 diabetes . However, it is still the favoured type of rice among consumers, contributing to the observed increasing trends in diet-related diseases in countries with high rice consumption . Modifying the properties of white rice products (e.g. reducing the glycaemic index and/or increasing satiety) with relatively simple interventions can contribute to producing foods that may promote better health due to modified digestion and post prandial metabolic and appetitive profiles. One way to reduce the glycaemic index of white rice may be the addition of hydrocolloids. These have previously been shown to modify the digestibility of foods . The health advantage derived from such modifications would be beneficial for consumers worldwide. Preliminary in-house in vitro digestion data suggested that the addition of gellan gum to rice cooking may reduce digestibility rates though mechanisms yet to be understood. Gellan gum (GG) "is a high molecular weight, water-soluble anionic, extracellular polysaccharide which is produced by the microorganism Sphingomonas elodea during fermentation". GG is commonly used as a gelling agent in foods. Gels formed by gellan gum have high resistance to acid, heat, and enzyme activity. The United States Food and Drug Administration (FDA) has approved the use of GG as a food additive for the human consumption (US.FDA, 2018). It is also approved by the European Community as a food additive with code (E-418). Gellan Gum is gluten free and broadly applied in gluten free foods to provide improved texture and good taste to pasta, biscuits, candy and dairy products. Therefore, it has been proved safe in the amounts the investigators intend to use, it is also suitable for people diagnosed with Coeliac disease as well as suitable for vegetarians, kosher and Halal diets, which make it acceptable for consumption and dietary intervention across different populations. AIM: The overall purpose of this study is to explore the impact of cooking rice with gellan on the glycaemic and appetitive responses in healthy participants. Both the acute response to one meal will be considered, and the impact on the acute response having consumed the rice once a day over the preceding 7 days. Tolerance will also be considered. HYPOTHESIS: This work will test the hypothesis that the addition of gellan gum to jasmine rice during cooking will reduce the post prandial glycaemic response. The investigators will also explore associated food intake, appetitive responses and tolerance during both the acute single meal exposure and over a 7 day period of consuming the same portion of rice each day, therefore testing the stability of the glycaemic and appetitive responses after a 7 day period of consumption. Establishing that any acute effect noted is sustained over a period of consumption will be important prior to recommending the addition of gellan to rice cooking as a therapeutic or public health strategy.


Recruitment information / eligibility

Status Completed
Enrollment 8
Est. completion date February 28, 2023
Est. primary completion date February 28, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Not currently taking any medications (except the oral contraceptive pill) - Aged 18-65 years old - Body mass index (BMI) = 18.5 and = 24.9 kg/m2 - Able to give informed consent - Apparently healthy: no medical conditions or previous gastrointestinal surgery which might affect study measurements. Exclusion Criteria: - Fasting finger prick screening blood sugar level higher than 5.4 mmol/L - Restrained eating behaviour as determined by Eating habits and SCOFF screening questionnaires - Participation in another nutritional or biomedical trial 3 months before the pre-study screening or during the study. - Reported participation in night shift work during the two weeks prior to pre-study investigation or during the study. Night work is defined as working between midnight and 6.00 AM. - Strenuous exercise for more than 10 hours per week. - Consumption of =21 alcoholic drinks in a typical week - Reported weight loss or gain = 10 % of bodyweight during the six months period before the pre-study examination. - Following a medically- or self-prescribed diet during the two weeks prior to the pre-study examination and until the end of the study - Dislike of the products served as the dietary test treatments - Any allergy or food intolerance to the test treatments - Pregnancy or breastfeeding declared by candidate - Antibiotic or prescribed probiotic treatment in the past 12 weeks - Poor understanding of the spoken and/or written English language - Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
White rice
185 g Jasmine (white) rice boiled in 356 g water
Gellan gum
Food grade hydrocolloid polysaccharide 5.5g dissolved in 356g cooking water containing 185g rice

Locations

Country Name City State
United Kingdom University of Nottingham Nottingham Nottinghamshire

Sponsors (3)

Lead Sponsor Collaborator
Moira Taylor Imam Abdulrahman Bin Faisal University, University of Copenhagen

Country where clinical trial is conducted

United Kingdom, 

References & Publications (5)

Azadbakht L, Haghighatdoost F, Esmaillzadeh A. White Rice Consumption, Body Mass Index, and Waist Circumference among Iranian Female Adolescents. J Am Coll Nutr. 2016 Aug;35(6):491-499. doi: 10.1080/07315724.2015.1113902. Epub 2016 Jun 17. — View Citation

Garcia MC, Alfaro MC, Calero N, Munoz J. Influence of polysaccharides on the rheology and stabilization of alpha-pinene emulsions. Carbohydr Polym. 2014 May 25;105:177-83. doi: 10.1016/j.carbpol.2014.01.055. Epub 2014 Jan 27. — View Citation

Golozar A, Khalili D, Etemadi A, Poustchi H, Fazeltabar A, Hosseini F, Kamangar F, Khoshnia M, Islami F, Hadaegh F, Brennan P, Boffetta P, Abnet CC, Dawsey SM, Azizi F, Malekzadeh R, Danaei G. White rice intake and incidence of type-2 diabetes: analysis of two prospective cohort studies from Iran. BMC Public Health. 2017 Jan 31;17(1):133. doi: 10.1186/s12889-016-3999-4. — View Citation

Mond JM, Myers TC, Crosby RD, Hay PJ, Rodgers B, Morgan JF, Lacey JH, Mitchell JE. Screening for eating disorders in primary care: EDE-Q versus SCOFF. Behav Res Ther. 2008 May;46(5):612-22. doi: 10.1016/j.brat.2008.02.003. Epub 2008 Feb 14. — View Citation

Yi Y, Jeon HJ, Yoon S, Lee SM. Hydrocolloids Decrease the Digestibility of Corn Starch, Soy Protein, and Skim Milk and the Antioxidant Capacity of Grape Juice. Prev Nutr Food Sci. 2015 Dec;20(4):276-83. doi: 10.3746/pnf.2015.20.4.276. Epub 2015 Dec 31. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Profile of post prandial 2 hour circulating blood glucose curve Fingerprick blood glucose profile for 2 hours post consumption of test rice samples. Over 2 hours post consumption
Secondary Profile of post prandial 3.5 hour circulating blood glucose curve Fingerprick blood glucose profile for 3.5 hours post consumption of test rice samples rs Over 3.5 hours post consumption
Secondary Time to Peak of blood glucose Fingerprick blood glucose time to peak Time period (during the 3.5 hour study period) until peak occurs in hours
Secondary Peak blood glucose Fingerprick blood glucose peak value During the 3.5 hour period of the study.
Secondary Appetite scores post prandial up to 3.5 hours up to 3.5 hours Curve of Visual Analogue Scores up to 3.5 hours postprandially Over 3.5 hours
Secondary Gastrointestinal tolerance scores up to 3.5 hours Symptom scores up to 3.5 hours postprandially Over 3.5 hours
Secondary Total amount of energy consumed on the first day Food intake measured from food diaries Over 24 hours
Secondary Explorative correlations Explorative correlations between Fingerprick blood glucose area under the curve for 2 hours and 3.5 hours and respectively Area under the curve of appetite Visual Analogue Scores up to 2 hours and 3.5 hours postprandially Over 2 hours and over 3.5 hours
Secondary Daily appetite scores measured using visual analogue scales Appetite score recorded twice daily morning and evening for 7 days using 100mm visual analogue scales with a minimum value of 0mm and maximum value of 100mm. Daily for 7 days
Secondary Gastrointestinal tolerance visual analogue scores questionnaire Symptom scores measured daily over 7 days using 100mm visual analogue scales with 0mm as as the minimum and 100mm as the maximum. Daily for 7 days
Secondary Gastrointestinal tolerance categorical questionnaire Symptom scores measured daily over 7 days using categorial scores with 0 as as the minimum and 3 as the maximum. Daily for 7 days
Secondary Daily total amount of energy consumed Food intake measured from food diaries daily for 7 days Daily for 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1